Evidence map›Paper›PMID 25232507›Full record

ReviewAmerican journal of stem cells2014

The Oct4 protein: more than a magic stemness marker.

Dana Zeineddine, Aya Abou Hammoud, Mohamad Mortada, Hélène Boeuf

Open access · greenAbstract readReview
In one paragraph

Review in American journal of stem cells, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. OCT4 and NANOG are involved in adrenocortical tumorigenesis.Archives of endocrinology and metabolism · 2026
    Article
  5. Article
  6. Review
  7. RUNX1T1 drives stem-like small-cell neuroendocrine prostate cancer identity.Frontiers in cell and developmental biology · 2026
    Article
  8. Xist in X chromosome inactivation: mechanisms and disease relevance.Cell communication and signaling : CCS · 2025
    Review
  9. Review
  10. Article
  11. eLife · 2025
    Article
  12. Review
  13. bioRxiv : the preprint server for biology · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Cancer stem cells in meningiomas: novel insights and therapeutic implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  18. Review
  19. The role of OCT4 and CD44 in lower lip carcinogenesis.Oral and maxillofacial surgery · 2025
    Article
  20. Targeted Cancer Stem Cell Therapeutics: An Update.Current topics in medicinal chemistry · 2025
    Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Dana ZeineddineLebanese University Beyrouth, Liban.
Aya Abou HammoudLebanese University Beyrouth, Liban ; Univ. Bordeaux, CIRID, UMR 5164 F-33 000 Bordeaux, France ; CNRS, CIRID, UMR 5164 F-33 000 Bordeaux, France.
Mohamad MortadaLebanese University Beyrouth, Liban.
Hélène BoeufUniv. Bordeaux, CIRID, UMR 5164 F-33 000 Bordeaux, France ; CNRS, CIRID, UMR 5164 F-33 000 Bordeaux, France.
Centre National de la Recherche Scientifique · FRLebanese University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Oct4 protein, encoded by the Pou5f1 gene was the very first master gene, discovered 25 years ago, to be absolutely required for the stemness properties of murine and primate embryonic stem cells. This transcription factor, which has also been shown to be essential for somatic cell reprogrammation, displays various functions depending upon its level of expression and has been quoted as a "rheostat" gene. Oct4 protein is in complexes with many different partners and its activity depends upon fine post-translational modifications. This review aims at revisiting some properties of this protein, which has not yet delivered all its potentialities.

Indexed as

cancer stem cellscell lineagesembryonic stem cellsOct4/ Pou5f1pluripotency

Identifiers

PMID25232507
PMCPMC4163606
OpenAlexW191170641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.